{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-15T14:36:48.618037+00:00","company":{"ticker":"UTMD","cik":706698,"company_name":"UTAH MEDICAL PRODUCTS INC"},"pagination":{"limit":100,"returned":12,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"shareholder_vote","fact_key":"4b4156c5945031821e96c947ea3b48c24c036a4d","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2026-05-04T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-01","outcome":"passed","proposal_text":"Advisory vote on executive compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"372,329","subject":null,"votes_abstain":"7,603","votes_against":"38,451","votes_for":"2,354,919","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Advisory vote on executive compensation at the 2026-05-01 meeting.","evidence_excerpt":"Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,354,919 Against  38,451 Abstentions 7,603     Broker Non-Votes 372,329","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-26-000685","anchor_url":"https://secwatch.observer/filing/0001096906-26-000685#claim-4b4156c5945031821e96c947ea3b48c24c036a4d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690626000685/0001096906-26-000685-index.htm"},{"fact_type":"shareholder_vote","fact_key":"5d35ae8d7157550719dd2f60fdca07128ca65ebc","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2026-05-04T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-01","outcome":"passed","proposal_text":"Ratification of Haynie & Co. as independent public accounting firm","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"3,751","votes_against":"16,273","votes_for":"2,753,278","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Ratification of Haynie & Co. as independent public accounting firm at the 2026-05-01 meeting.","evidence_excerpt":"Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2026: For 2,753,278 Against 16,273 Abstentions 3,751","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-26-000685","anchor_url":"https://secwatch.observer/filing/0001096906-26-000685#claim-5d35ae8d7157550719dd2f60fdca07128ca65ebc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690626000685/0001096906-26-000685-index.htm"},{"fact_type":"shareholder_vote","fact_key":"16b4834f5c3eef94be659994bf41ddf07c44d69e","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2026-05-04T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-01","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"372,329","subject":"Ernst G. Hoyer","votes_abstain":null,"votes_against":null,"votes_for":"1,330,333","votes_withheld":"1,070,640"},{"broker_non_votes":"372,329","subject":"James H. Beeson","votes_abstain":null,"votes_against":null,"votes_for":"1,708,941","votes_withheld":"692,032"}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Election of Directors at the 2026-05-01 meeting.","evidence_excerpt":"Elected Ernst G. Hoyer as a director of the Company: For 1,330,333 Withheld 1,070,640 Broker Non-Votes 372,329 Elected James H. Beeson as a director of the Company: For 1,708,941 Withheld 692,032 Broker Non-Votes 372,329","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-26-000685","anchor_url":"https://secwatch.observer/filing/0001096906-26-000685#claim-16b4834f5c3eef94be659994bf41ddf07c44d69e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690626000685/0001096906-26-000685-index.htm"},{"fact_type":"executive_change","fact_key":"41c1e3cfbb","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2024-11-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Carrie Leigh was appointed as Director at UTAH MEDICAL PRODUCTS INC.","evidence_excerpt":"On November 1, 2024, the Board of Directors of Utah Medical Products, Inc. (UTMD) voted to increase the size of the Board of Directors from five to six members and to appoint Carrie Leigh to fill the vacancy created by the increase in the number of directors.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001096906-24-002072","anchor_url":"https://secwatch.observer/filing/0001096906-24-002072#claim-41c1e3cfbb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690624002072/0001096906-24-002072-index.htm"},{"fact_type":"shareholder_vote","fact_key":"78236c067286e0747caad985df34d2e994e5ed94","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2024-05-06T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-03","outcome":"passed","proposal_text":"Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion","proposal_type":"say_on_pay","results":[{"broker_non_votes":"324,644","subject":null,"votes_abstain":"6,064","votes_against":"72,899","votes_for":"2,662,106","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion at the 2024-05-03 meeting.","evidence_excerpt":"Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,662,106 Against  72,899 Abstentions 6,064     Broker Non Votes 324,644","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-24-001026","anchor_url":"https://secwatch.observer/filing/0001096906-24-001026#claim-78236c067286e0747caad985df34d2e994e5ed94","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690624001026/0001096906-24-001026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"88295bd198c638e54aecc5fd3f75eb6c0f36e070","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2024-05-06T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-03","outcome":"passed","proposal_text":"Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"3,469","votes_against":"49,443","votes_for":"3,012,801","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024 at the 2024-05-03 meeting.","evidence_excerpt":"Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024: For 3,012,801 Against 49,443 Abstentions 3,469","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-24-001026","anchor_url":"https://secwatch.observer/filing/0001096906-24-001026#claim-88295bd198c638e54aecc5fd3f75eb6c0f36e070","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690624001026/0001096906-24-001026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"df7c4a2558c344f5976b64903157700dbaf3d4f9","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2024-05-06T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-03","outcome":"passed","proposal_text":"Elected Kevin L. Cornwell as a director of the Company","proposal_type":"director_election","results":[{"broker_non_votes":"324,644","subject":"Kevin L. Cornwell","votes_abstain":null,"votes_against":null,"votes_for":"1,436,389","votes_withheld":"1,304,680"},{"broker_non_votes":"324,644","subject":"Paul O. Richins","votes_abstain":null,"votes_against":null,"votes_for":"907,483","votes_withheld":"1,833,586"}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Elected Kevin L. Cornwell as a director of the Company at the 2024-05-03 meeting.","evidence_excerpt":"Elected Kevin L. Cornwell as a director of the Company: For 1,436,389 Withheld 1,304,680 Broker Non Votes 324,644 Elected Paul O. Richins as a director of the Company: For 907,483 Withheld 1,833,586 Broker Non Votes 324,644","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-24-001026","anchor_url":"https://secwatch.observer/filing/0001096906-24-001026#claim-df7c4a2558c344f5976b64903157700dbaf3d4f9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690624001026/0001096906-24-001026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"40608398d612e4b899c2d27ce63ed18ccfc116f0","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2023-05-08T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-05","outcome":"passed","proposal_text":"Frequency of future advisory votes on executive compensation","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"371,084","subject":null,"votes_abstain":"199,248","votes_against":null,"votes_for":"2,412,492","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Frequency of future advisory votes on executive compensation at the 2023-05-05 meeting.","evidence_excerpt":"Indicated a preference, the frequency of future advisory votes on the Company's executive compensation program: Every year: 2,412,492 Every two years: 17,765 Every three years: 167,728 Abstain: 199,248 Broker Non Votes: 371,084","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-23-000990","anchor_url":"https://secwatch.observer/filing/0001096906-23-000990#claim-40608398d612e4b899c2d27ce63ed18ccfc116f0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm"},{"fact_type":"shareholder_vote","fact_key":"f2bf1f614874fc564cb1b9f2eeb87dc576f47954","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2023-05-08T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-05","outcome":"passed","proposal_text":"Advisory vote on executive compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"371,084","subject":null,"votes_abstain":"4,781","votes_against":"72,499","votes_for":"2,719,953","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Advisory vote on executive compensation at the 2023-05-05 meeting.","evidence_excerpt":"Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,719,953 Against 72,499 Abstentions 4,781 Broker Non Votes 371,084","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-23-000990","anchor_url":"https://secwatch.observer/filing/0001096906-23-000990#claim-f2bf1f614874fc564cb1b9f2eeb87dc576f47954","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm"},{"fact_type":"shareholder_vote","fact_key":"c28df9a41bb68ea3af6e998ed15a2353db4fd169","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2023-05-08T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-05","outcome":"passed","proposal_text":"Ratification of Haynie & Co. as independent public accounting firm","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"2,601","votes_against":"27,552","votes_for":"3,138,164","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Ratification of Haynie & Co. as independent public accounting firm at the 2023-05-05 meeting.","evidence_excerpt":"Ratified the selection of Haynie & Co. as the Company's independent public accounting firm for the year ended December 31, 2023: For 3,138,164 Against 27,552 Abstentions 2,601","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-23-000990","anchor_url":"https://secwatch.observer/filing/0001096906-23-000990#claim-c28df9a41bb68ea3af6e998ed15a2353db4fd169","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm"},{"fact_type":"shareholder_vote","fact_key":"4cc69cfbc7070e678e9e2673893a1abfd96f38ee","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2023-05-08T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-05","outcome":"failed","proposal_text":"2023 Employees’ and Directors’ Incentive Plan","proposal_type":"equity_plan","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"38,085","votes_against":"1,590,668","votes_for":"1,168,480","votes_withheld":null}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders rejected 2023 Employees’ and Directors’ Incentive Plan at the 2023-05-05 meeting.","evidence_excerpt":"Did not approve the 2023 Employees’ and Directors’ Incentive Plan: For 1,168,480 Against 1,590,668 Abstentions 38,085","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-23-000990","anchor_url":"https://secwatch.observer/filing/0001096906-23-000990#claim-4cc69cfbc7070e678e9e2673893a1abfd96f38ee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm"},{"fact_type":"shareholder_vote","fact_key":"37b484ec0ee278d5d7e232ed4934850c8f313366","cik":706698,"ticker":"UTMD","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2023-05-08T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-05","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"371,084","subject":"Ernst G. Hoyer","votes_abstain":null,"votes_against":null,"votes_for":"871,160","votes_withheld":"1,926,073"},{"broker_non_votes":"371,084","subject":"James H. Beeson","votes_abstain":null,"votes_against":null,"votes_for":"1,277,218","votes_withheld":"1,520,015"}]},"claim":"UTAH MEDICAL PRODUCTS INC shareholders approved Election of Directors at the 2023-05-05 meeting.","evidence_excerpt":"Elected Ernst G. Hoyer as a director of the Company: For 871,160 Withheld 1,926,073 Broker Non Votes 371,084 Elected James H. Beeson as a director of the Company: For 1,277,218 Withheld 1,520,015 Broker Non Votes 371,084","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001096906-23-000990","anchor_url":"https://secwatch.observer/filing/0001096906-23-000990#claim-37b484ec0ee278d5d7e232ed4934850c8f313366","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm"}]}